000
| 01019nam##2200289za#4500 |
---|
001 | 9.615043 |
---|
003 | CaOODSP |
---|
005 | 20210615100949 |
---|
007 | ta |
---|
008 | 150406|2000||||xxc||||| f|0| 0 eng|d |
---|
020 | |a0-662-28442-9 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH42-2/67-15-1999E |
---|
110 | 1 |aCanada. |bHealth Products and Food Branch. |
---|
245 | 10|aAddendum to "Dose selection for carcinogenicity studies of pharmaceuticals" : |baddition of a limit dose and related notes |
---|
260 | |aOttawa - Ontario : |bHealth Canada. |c2000. |
---|
300 | |ai, 2p. ; |c28 cm. |
---|
490 | 1 |aGuidance for industry|vICH topic S1C (R) |
---|
563 | |aLoose-leaf |
---|
590 | |a01-25|b2001-06-22 |
---|
690 | 07|aTesting|2gcpds |
---|
690 | 07|aCancer|2gcpds |
---|
690 | 07|aDrugs|2gcpds |
---|
690 | 07|aPharmaceutical industry|2gcpds |
---|
776 | 0#|tAddendum to "Dose selection for carcinogenicity studies of pharmaceuticals" : |w(CaOODSP)9.573937 |
---|
830 | #0|aGuidance for industry ;|vICH topic S1C (R)|w(CaOODSP)9.514730 |
---|